FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention proposes analgesic agent possessing the analgesic effect showing effectiveness against the pain by effect on nociceptors. As an active component the proposed analgesic agent comprises compound represented by the general formula (1) 
or its salt wherein X, Y, E, Q, A1, A2, R1, R3, R4, R5, R2A, R2C, R2D and R2B re determined in the invention claim.
EFFECT: valuable medicinal properties of agents.
3 tbl, 70 ex
| Title | Year | Author | Number |
|---|---|---|---|
| QUINAZOLINE DERIVATIVES AS INHIBITORS OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) | 2000 |
|
RU2291868C2 |
| DERIVATIVES OF N-ACYL-α-AMINO ACID OR THEIR PHYSIOLOGICALLY ACCEPTABLE SALTS, SIMPLE ETHERS OR ESTERS, AMIDES OR HYDRATES AND COMPOSITION INHIBITING ADHESIVE PROTEINS BINDING WITH PLATELETS AND PLATELET AGGREGATION | 1992 |
|
RU2097378C1 |
| QUINAZOLINE COMPOUNDS | 2003 |
|
RU2365588C2 |
| QUINAZOLINE DERIVATIVES, METHOD FOR THEIR PREPARING AND PHARMACEUTICAL COMPOSITION | 2001 |
|
RU2267489C2 |
| ETHYLENEDIAMINE DERIVATIVES AND FXa INHIBITOR AND ANTICOAGULANT COMPRISING THEREOF | 2001 |
|
RU2268259C2 |
| DERIVATIVES OF QUINAZOLINE AS INHIBITORS OF ANGIOGENESIS | 2000 |
|
RU2262935C2 |
| SERINE PROTEASE INHIBITOR AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1999 |
|
RU2232760C2 |
| SUBSTITUTED AMINOBUTYRIC DERIVATIVES AS NEPRILYSIN INHIBITORS | 2012 |
|
RU2604522C2 |
| TAXANES, PHARMACEUTICAL COMPOSITIONS, INHIBITION METHOD | 2001 |
|
RU2265019C2 |
| PYRIDOPYRIMIDINE INHIBITORS CDK2/4/6 | 2017 |
|
RU2726115C1 |
